AustralianSuper’s Edwards Lifesciences EW Stock Holding History

AustralianSuper’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-559,115	Closed	-$43.7M	–	277
2025 Q2	$43.7M	Sell	559,115 -984,313	-64%	-$73.4M	0.22%	103
2025 Q1	$112M	Sell	1,543,428 -1,125,415	-42%	-$80.6M	0.63%	48
2024 Q4	$198M	Sell	2,668,843 -604,573	-18%	-$42.3M	0.93%	24
2024 Q3	$216M	Buy	3,273,416 +494,604	+18%	+$35.9M	1.08%	22
2024 Q2	$257M	Buy	2,778,812 +344,465	+14%	+$30.5M	1.48%	13
2024 Q1	$229M	Buy	2,434,347 +224,264	+10%	+$18.8M	1.34%	17
2023 Q4	$169M	Buy	+2,210,083	New	+$154M	1.01%	27
2021 Q2	–	Sell	-2,518,947	Closed	-$211M	–	168
2021 Q1	$211M	Hold	2,518,947	–	–	1.65%	25
2020 Q4	$230M	Buy	2,518,947 +63,357	+3%	+$5.26M	1.72%	21
2020 Q3	$196M	Buy	2,455,590 +694,177	+39%	+$54.2M	1.67%	21
2020 Q2	$122M	Buy	+1,761,413	New	+$125M	1.18%	35

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

AustralianSuper's EW Position: Q3 2025 in Review

AustralianSuper sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 559,115 shares — an estimated $43.7M sold.

AustralianSuper first reported a position in EW in Q2 2020 and held it in 11 quarters. The position peaked at $257M in Q2 2024. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

AustralianSuper reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
AustralianSuper sold 559,115 Edwards Lifesciences shares in Q3 2025, an estimated $43.7M.
AustralianSuper first reported a position in Edwards Lifesciences in Q2 2020 and held it in 11 quarters.
AustralianSuper's Edwards Lifesciences position peaked at $257M in Q2 2024.
1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on AustralianSuper's 13F filing for Q3 2025, filed 3 Nov 2025.